Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00575744 · ClinicalTrials.gov registry record · Phase 2
Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
A Phase 2 study, sponsored by University of Arkansas.
- Completed
- Registry status
- Phase 2
- Development phase
- 699
- Enrollment target
NCT00575744: Completed Phase 2 study, sponsored by University of Arkansas.
NCT00575744 is a Phase 2 study that has completed, run by University of Arkansas. The registered enrollment target is 699 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (426% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00575744, a Phase 2 study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 699 participants
- Enrollment target
Study Summary
We continue to collect information in support of the hypothesis that the histology of the first draining lymph node (sentinel node) accurately predicts the histology of the rest of the axillary lymph nodes.
Interventions
- PROCEDURE Sentinel Node Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 699 participants |
| Start Date | 1998-12 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
What the finished NCT00575744 record still lists
NCT00575744 is an interventional study that assigns participants to a tested intervention. The registered 699 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (426% higher).
The record links to 0 conditions, and to 1 intervention - of which Sentinel Node Biopsy is the first listed.
NCT00575744 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00575744 about?
NCT00575744 is a clinical study titled "Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation". We continue to collect information in support of the hypothesis that the histology of the first draining lymph node (sentinel node) accurately predicts the histology of the rest of the axillary lymph nodes.
What is the current status of trial NCT00575744?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 699 participants. The study started on 1998-12. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00575744?
The interventions under investigation include: Sentinel Node Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00575744?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00575744's enrollment target sits among peer trials
699 46th of 2000 higher than 1,955 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07187115 · 699 participants · NA
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia